Pharmaceuticals, Biotechnology and Life Sciences
This marks the first major regulatory approval of a vaccine developed by Janssen The Ebola vaccine regimen leverages Janssen’s AdVac®…
An experimental treatment cured 100 percent of guinea pigs and rhesus monkeys in late stages of infection with lethal levels of Marburg and Ravn viruses, relatives of the Ebola virus.
Johnson & Johnson has started a safety and immunogenicity clinical trial in Sierra Leone of a preventive Ebola vaccine regimen in development at its Janssen Pharmaceutical Companies.
Watch a video and take a look at the U.S. government’s response in addressing Ebola in the United States.
Johnson & Johnson has Announced BARDA Funding Award to Accelerate Ebola Vaccine Program Prime-boost vaccine regimen in development at the…